PCRX

Pacira Pharmaceuticals, Inc. News Headlines

$101.54
*  
4.93
4.63%
Get PCRX Alerts
*Delayed - data as of Jan. 28, 2015  -  Find a broker to begin trading PCRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PCRX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Pacira Pharmaceuticals, Inc. (PCRX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/16/2015 7:00:00 AM - Investopedia


Update: Pacira's Q4 Revenue Expectations
1/10/2015 8:57:00 AM - Seeking Alpha


Pacira Q4 & 2014 Revenues to Come In Line with Estimates - Analyst Blog
1/9/2015 4:20:00 PM - Zacks.com


Pacira Q4 & 2014 Revenues to Come In Line with Estimates - Analyst Blog
1/9/2015 4:20:00 AM - Investopedia


Health Care Sector Update for 01/08/2015: ISIS, MNKD, FOLD, PCRX
1/8/2015 8:33:59 AM - MT Newswires


Pacira Pharma Sees Q4, 2014 Revenues Above Estimates - Quick Facts
1/8/2015 6:47:00 AM - RTT News


Interesting PCRX Put And Call Options For August 21st
1/6/2015 11:05:05 AM - BNK Invest


3 Incredible Growth Stocks to Watch in 2015 - Analyst Blog
1/6/2015 9:45:00 AM - Investopedia


3 Incredible Growth Stocks to Watch in 2015 - Analyst Blog
1/6/2015 9:45:00 AM - Zacks.com


Notable Two Hundred Day Moving Average Cross - PCRX
1/5/2015 5:21:18 PM - BNK Invest


New Biotech ETF From ALPS
1/2/2015 8:05:16 AM - Benzinga


SPDR S&P Pharmaceuticals ETF -- Insider Buying Index Registering 10.1%
12/30/2014 10:15:11 AM - BNK Invest


ASPX Flies On Trial Data, CYCC Knocked Down, NVGN Creates Buzz, BVX On Watch
12/16/2014 11:44:00 PM - RTT News


Pacira Pharmaceuticals To Participate In Piper Jaffray Conference At 8:30 AM ET
12/2/2014 7:32:00 AM - RTT News


Pacira: Should You Buy The Dip?
11/6/2014 10:16:00 AM - Seeking Alpha


Pacira Down on Wider than Expected Q3 Loss, Sales Miss - Analyst Blog
10/31/2014 12:00:00 PM - Zacks.com


Astellas Files for Amendment of Isavuconazole Study Protocol - Analyst Blog
10/17/2014 4:15:00 PM - Zacks.com


Pacira Pharmaceuticals, Inc. (PCRX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
10/17/2014 7:00:00 AM - Zacks.com


Pacira Pharmaceuticals (PCRX): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape
10/16/2014 7:45:00 AM - Zacks.com


Sucampo/Takeda Amend Collaboration Agreement for Amitiza - Analyst Blog
10/15/2014 5:07:00 PM - Zacks.com


Pacira (PCRX) Reveals Additional Safety Data on Exparel - Analyst Blog
10/14/2014 4:45:00 PM - Zacks.com


Avanir (AVNR) Presents Detailed Phase II Data on AVP-923 - Analyst Blog
10/14/2014 4:30:00 PM - Zacks.com


Astellas' New Data on Cresemba for Invasive Mucormycosis - Analyst Blog
10/9/2014 4:30:00 PM - Zacks.com


Heat Biologics Completes Dosing for Vesigenurtacel-L Trial - Analyst Blog
10/9/2014 2:54:00 PM - Zacks.com


Alcobra Reveals ADHD Top-line Phase III Data, Shares Down - Analyst Blog
10/8/2014 1:28:00 PM - Zacks.com